The Accounting Trick Behind Aequs's Big Loss

The strangest number in Aequs's Q1 FY27 earnings is the one that isn't there. Revenue jumped 55% to nearly ₹400 crore (₹4 billion). Aerospace EBITDA grew 35% year-on-year. The company posted a net loss of ₹53.2 crore.

A year ago, it posted a small profit. Between the two quarters, a manufacturing company somehow went from making money to losing more than it brings in on a profit-after-tax basis. The headline frame from the company is "revenue surges, losses narrow sequentially." That is technically true. It is also the sort of sentence that sounds fine until you look at what changed on the income sheet.

The basic point is that Aequs didn't suddenly become unprofitable. It stopped hiding costs on the balance sheet.

Here is the mechanism. Aequs runs two businesses: aerospace manufacturing, which is mature and profitable, and consumer electronics manufacturing, which is newly commercial and not yet profitable. In Q1 FY26, the consumer segment hadn't formally started commercial operations, so its operating costs were capitalized - recorded as assets on the balance sheet rather than expenses on the income statement. This quarter, commercial operations are live. Those same costs are now expensed. They hit the income sheet as ₹36.1 crore of EBITDA losses - EBITDA is earnings before interest, taxes, depreciation, and amortization, a rough proxy for operating cash flow.

That accounting shift - from capitalized to expensed - is the primary driver of the profit-to-loss swing. It's not a change in economics. It's a change in where the numbers live.

The consumer segment also grew enormously in size during the quarter. Revenue nearly tripled year-on-year to ₹73.4 crore, or 19% of the consolidated total, up from 10% a year ago. Revenue nearly tripling while the segment loses nearly half of what it brings in is not a surprise for a greenfield manufacturing facility. It's a utilization problem. Consumer capacity utilization was 22% this quarter, up from about 18% a year ago. The machines are sitting there. The depreciation and fixed costs are running whether the machines are busy or not.

So far, ordinary capital-intensive business. But here's the part that is actually weird: the company is spending ₹500 crore on new consumer capacity this year, even while existing capacity is idle.

Management's answer is that not scaling up risks losing customers. Hasbro and Mattel are in the pipeline, and the logic is that if Aequs doesn't build the room, the customers will go elsewhere. That is a real concern in contract manufacturing. But it is also the sort of promise that is expensive to prove wrong. The company's five-year plan includes ₹2,800 crore of total capex in Karnataka, and the consumer division is supposed to grow to 40–60% of total revenue over the next five years. In other words, Aequs is trying to become a consumer electronics manufacturer while it is still running an aerospace company. The aerospace part works. The consumer part is a bet.

Let me be specific about what the bet requires. Management said consumer EBITDA breakeven is targeted for Q4 FY27, with utilization needing to climb from the current 22% to 40–50%. Long-term, both segments are supposed to settle at similar EBITDA margins of 18–20%. Consolidated breakeven is expected in the first half of FY28.

The simplest model for that is: utilization is the margin switch. At 22%, the consumer division is hemorrhaging fixed costs over too few units. At 40–50%, the fixed cost per unit drops enough that the contribution margin covers the overhead. That is standard manufacturing math. The question is whether orders arrive fast enough. The ₹500 crore capex is supposed to make them arrive, by giving customers a reason to send volume to India. It's a chicken-and-egg cycle: capacity attracts orders, orders justify capacity. The risk is that you build the capacity, and the orders are still slow to show up, and now you have more idle machines burning cash.

The aerospace side is the part that has actually earned the valuation. The order book crossed $1 billion during the quarter, up 13% sequentially, and includes a new 15-year contract with Safran Landing Systems for fully assembled Airbus A320 wheels - manufactured end-to-end in India. Aerospace utilization is 70% overall, 78% for domestic capacity. EBITDA margins are in the low 20s, with the segment generating ₹73.1 crore of EBITDA this quarter alone. This is a steady, profitable machine with a long backlog. The stock's roughly ₹14,500 crore market cap is mostly pricing in the continuation of this business.

The consumer segment is the part that adds a question mark. As of late July, the company's market cap stood at roughly ₹14,500 crore, a generous valuation for a business where one segment is still proving it can earn its keep.

There is one other item worth noting. The board advanced a merger of subsidiaries and reversed a prior bonus provision during the quarter. These are small enough not to change the thesis, but they suggest management is tidying up the corporate structure as it enters a heavy capex phase. (Reversing a bonus provision also adds back money to the bottom line, which is a small but real source of accounting generosity.)

Anyway, the economic point is straightforward. Aequs's Q1 loss is not a surprise. It's an accounting migration - costs that used to live on the balance sheet now live on the income sheet - layered on top of a real strategic gamble. The consumer division is burning cash because utilization is too low. The response is to spend more money building capacity, on the theory that capacity drives utilization. That can work. It can also mean spending your way into a utilization trap where the new capacity sits idle alongside the old one.

The market is pricing in that the aerospace business keeps printing and the consumer division eventually catches up. That is a workable story if the 40–50% utilization target hits by year-end. It's fragile if it doesn't. The number that matters is not the earnings result. It's the utilization curve.